Pacira BioSciences, Ownership

PCRX Stock  USD 25.48  0.38  1.51%   
The majority of Pacira BioSciences, outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Pacira BioSciences, to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Pacira BioSciences,. Please pay attention to any change in the institutional holdings of Pacira BioSciences, as this could imply that something significant has changed or is about to change at the company.
Some institutional investors establish a significant position in stocks such as Pacira BioSciences, in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Pacira BioSciences,, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacira BioSciences,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences, guide.

Pacira Stock Ownership Analysis

About 97.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.55. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pacira BioSciences, recorded a loss per share of 1.98. The entity had not issued any dividends in recent years. Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida. Pacira Pharm operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 697 people. To find out more about Pacira BioSciences, contact David Stack at 813 553 6680 or learn more at https://www.pacira.com.

Pacira BioSciences, Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pacira BioSciences, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pacira BioSciences,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Pacira BioSciences, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Slonin Jonathan over a month ago
Disposition of 879 shares by Slonin Jonathan of Pacira BioSciences, at 18.4 subject to Rule 16b-3
 
Daryl Gaugler over a month ago
Acquisition by Daryl Gaugler of 243 shares of Pacira BioSciences, at 16.014 subject to Rule 16b-3
 
Lauren Riker over a month ago
Acquisition by Lauren Riker of 25000 shares of Pacira BioSciences, at 38.74 subject to Rule 16b-3
 
Shawn Cross over three months ago
Acquisition by Shawn Cross of 200000 shares of Pacira BioSciences, at 16.45 subject to Rule 16b-3
 
Shawn Cross over three months ago
Acquisition by Shawn Cross of 75000 shares of Pacira BioSciences, subject to Rule 16b-3
 
Brege Laura over three months ago
Acquisition by Brege Laura of 1000 shares of Pacira BioSciences, at 12.81 subject to Rule 16b-3
 
Pace Gary W over three months ago
Disposition of 1066 shares by Pace Gary W of Pacira BioSciences, at 29.67 subject to Rule 16b-3
 
Pace Gary W over three months ago
Acquisition by Pace Gary W of 1775 shares of Pacira BioSciences, subject to Rule 16b-3
 
Daryl Gaugler over three months ago
Disposition of 500 shares by Daryl Gaugler of Pacira BioSciences, at 12.86 subject to Rule 16b-3
 
Lauren Riker over three months ago
Disposition of 5773 shares by Lauren Riker of Pacira Pharmaceuticals at 38.52 subject to Rule 16b-3
 
Brege Laura over six months ago
Acquisition by Brege Laura of 1000 shares of Pacira Pharmaceuticals at 12.81 subject to Rule 16b-3
 
Yang Michael J. over six months ago
Acquisition by Yang Michael J. of 2000 shares of Pacira Pharmaceuticals at 12.9 subject to Rule 16b-3

Pacira BioSciences, Outstanding Bonds

Pacira BioSciences, issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pacira BioSciences, uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pacira bonds can be classified according to their maturity, which is the date when Pacira BioSciences, has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pacira Stock Analysis

When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.